Regeneron Pharmaceuticals · Change in Working Capital

Latest reported$392.40Mperiod endingJun 30, 2026

REGN Change in Working Capital (-$600.00K → $392.40M)

Annual change in working capital

High-resolution chart · PNG

REGN change in working capital history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Change in Working Capital — Annual fiscal periods (USD)
Period ending	Change in Working Capital (USD)
Dec 31, 2025	532,600,000
Dec 31, 2024	-618,300,000
Dec 31, 2023	-94,100,000
Dec 31, 2022	-243,300,000
Dec 31, 2021	-1,916,500,000
Dec 31, 2020	-1,503,600,000
Dec 31, 2019	-200,500,000
Dec 31, 2018	-697,000,000
Dec 31, 2017	-926,533,000
Dec 31, 2016	228,190,000
Dec 31, 2015	229,827,000
Dec 31, 2014	20,239,000
Dec 31, 2013	-190,669,000
Dec 31, 2012	-672,799,000
Dec 31, 2011	-17,464,000
Dec 31, 2010	140,935,000
Dec 31, 2009	-49,468,000
Dec 31, 2008	-52,434,000
Dec 31, 2007	87,467,000
Dec 31, 2006	92,958,000
Dec 31, 2005	27,787,000
Dec 31, 2004	-58,743,000
Dec 31, 2003	84,326,000
Dec 31, 2002	3,580,000
Dec 31, 2001	11,015,000
Dec 31, 2000	-15,254,000
Dec 31, 1999	1,200,000
Dec 31, 1998	-7,400,000
Dec 31, 1997	-2,600,000
Dec 31, 1996	-8,500,000
Dec 31, 1995	-14,800,000
Dec 31, 1994	-3,000,000
Dec 31, 1993	3,100,000
Dec 31, 1992	1,500,000
Dec 31, 1991	-600,000